| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10735-007-9136-Z |
| P698 | PubMed publication ID | 17885814 |
| P2093 | author name string | Christian Dombrowski | |
| Simon M Cool | |||
| Victor Nurcombe | |||
| David A Rider | |||
| Arjuna Kumarasuriyar | |||
| P2860 | cites work | Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity | Q24635382 |
| Heparin binding by the HIV-1 tat protein transduction domain | Q24644337 | ||
| Tyrosine sulfation is a trans-Golgi-specific protein modification | Q24680180 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans | Q28140638 | ||
| Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size | Q28235546 | ||
| Heparan sulfate is required for bone morphogenetic protein-7 signaling | Q28570924 | ||
| Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands | Q28580077 | ||
| Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans | Q28584264 | ||
| Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells | Q28609132 | ||
| In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Functions of cell surface heparan sulfate proteoglycans | Q29618521 | ||
| Cellular uptake of the tat protein from human immunodeficiency virus | Q29620627 | ||
| Heparan sulfate: lessons from knockout mice | Q30689506 | ||
| Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans. | Q30841060 | ||
| Herpes simplex virus: discovering the link between heparan sulphate and hereditary bone tumours | Q31676400 | ||
| Measurement of the anchorage force between GPI-anchored alkaline phosphatase and supported membranes by AFM force spectroscopy | Q33215159 | ||
| Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment | Q33596699 | ||
| Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization | Q34035649 | ||
| Chlorate--a potent inhibitor of protein sulfation in intact cells | Q34162808 | ||
| Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters | Q34184281 | ||
| Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion | Q34193846 | ||
| Protein transduction: an alternative to genetic intervention? | Q34279314 | ||
| Glycomics approach to structure-function relationships of glycosaminoglycans | Q34546553 | ||
| Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein | Q34556566 | ||
| Heparan sulfate fine structure and specificity of proteoglycan functions | Q34989559 | ||
| Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice | Q35094674 | ||
| Isolation and expression in Escherichia coli of hepB and hepC, genes coding for the glycosaminoglycan-degrading enzymes heparinase II and heparinase III, respectively, from Flavobacterium heparinum | Q35192351 | ||
| Endocytosis and targeting of exogenous HIV-1 Tat protein | Q35926764 | ||
| Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration | Q77658726 | ||
| Chondroitin sulfate in palatal wound healing | Q80908295 | ||
| Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly | Q36324847 | ||
| Protein transduction technology: a novel therapeutic perspective. | Q36409999 | ||
| Sulfated oligosaccharides and tumor: promoter or inhibitor? | Q36457707 | ||
| Evidence for the role of proteoglycans in cation-mediated gene transfer | Q37236667 | ||
| Genetic analysis of proteoglycan structure, function and metabolism | Q37421925 | ||
| The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation | Q37506941 | ||
| Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells | Q37867875 | ||
| Chlorate-induced inhibition of tyrosine sulfation on bone sialoprotein synthesized by a rat osteoblast-like cell line (UMR 106-01 BSP). | Q38311005 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Biosynthesis and properties of a further member of the small chondroitin/dermatan sulfate proteoglycan family. | Q38337765 | ||
| Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors. | Q40462664 | ||
| Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2alpha pathway in human osteoblastic MG63 cells. | Q40476129 | ||
| Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. | Q40591045 | ||
| The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex | Q40668417 | ||
| Proteoglycan gene targeting in somatic cells | Q40792993 | ||
| Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate | Q40912886 | ||
| Transduced p16INK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. | Q40949259 | ||
| Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor | Q41140266 | ||
| A proteoglycan that activates fibroblast growth factors during early neuronal development is a perlecan variant | Q41153435 | ||
| Estradiol beta-D-xyloside, an efficient primer for heparan sulfate biosynthesis. | Q41687433 | ||
| The effect of beta-D-xylosides on the proliferation and proteoglycan biosynthesis of monoblastic U-937 cells | Q41744456 | ||
| Altered proteoglycan synthesis via the false acceptor pathway can be dissociated from beta-D-xyloside inhibition of proliferation | Q42817134 | ||
| Removal of proteoglycans increases efficiency of retroviral gene transfer | Q42817599 | ||
| The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence | Q42819788 | ||
| Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts | Q43658155 | ||
| Purification and characterization of heparin lyases from Flavobacterium heparinum | Q43893111 | ||
| Tumor attenuation by 2(6-hydroxynaphthyl)-beta-D-xylopyranoside requires priming of heparan sulfate and nuclear targeting of the products. | Q44725183 | ||
| PDX-1 protein containing its own antennapedia-like protein transduction domain can transduce pancreatic duct and islet cells | Q45192671 | ||
| Use of vaccinia virus vectors to study the synthesis, intracellular localization, and action of the human immunodeficiency virus trans-activator protein | Q45841549 | ||
| BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. | Q46722498 | ||
| Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development | Q47071537 | ||
| Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. | Q47448961 | ||
| Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development | Q47895070 | ||
| Heparan sulphate proteoglycans and spinal neurulation in the mouse embryo. | Q52121142 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| TAT-mediated endocytotic delivery of the loop deletion Bcl-2 protein protects neurons against cell death | Q57374230 | ||
| Binding of vitronectin-thrombin-antithrombin III complex to human endothelial cells is mediated by the heparin binding site of vitronectin | Q67894989 | ||
| Beta-D-xyloside induced modulations of glycosaminoglycans, proliferation, and cytoskeletal organization of rat liver myofibroblast-like cells (transformed fat storing cells) | Q68033008 | ||
| Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells | Q70282524 | ||
| Tumor formation dependent on proteoglycan biosynthesis | Q70401546 | ||
| Delivering information-rich drugs--prospects and challenges | Q71818051 | ||
| Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor | Q72259934 | ||
| Role of heparan sulfate in the terminal differentiation of growth plate chondrocytes | Q72494018 | ||
| Biosynthesis of heparan sulfate on beta-D-xylosides depends on aglycone structure | Q72695062 | ||
| Significant role of adhesion properties of primary osteoblast-like cells in early adhesion events for chondroitin sulfate and dermatan sulfate surface molecules | Q72993223 | ||
| Modulation of sulfated glycosaminoglycan and small proteoglycan synthesis by the extracellular matrix | Q73814766 | ||
| Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria | Q74450390 | ||
| Heparan sulfate depletion within pulmonary fibroblasts: implications for elastogenesis and repair | Q74479617 | ||
| Expression of adhesion molecules by lp(a): a potential novel mechanism for its atherogenicity | Q77630824 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 435-447 | |
| P577 | publication date | 2007-09-21 | |
| P1433 | published in | Journal of Molecular Histology | Q2162212 |
| P1476 | title | A novel use of TAT-EGFP to validate techniques to alter osteosarcoma cell surface glycosaminoglycan expression | |
| P478 | volume | 38 |
| Q33811185 | An unusual cell penetrating peptide identified using a plasmid display-based functional selection platform |
| Q36980418 | Control of cell fate decisions |
| Q36080838 | Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake. |
| Q39850094 | TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression |
Search more.